Drowsiness with very high blood sugar, or confusion with sweating and shaking, needs emergency care now. Also seek urgent care for a foot ulcer with fever or spreading redness, which can progress rapidly in diabetes.
The commonest reason bariatric surgery is now described as metabolic surgery. Its effect on blood sugar begins within days, before meaningful weight is lost, through changes in gut hormones rather than weight alone.
The single most important factor is how long you have had diabetes. Remission is considerably more likely in someone diagnosed three years ago than in someone who has been insulin-dependent for fifteen.
Type 2 diabetes develops when the body becomes resistant to insulin and the pancreas cannot compensate. It is strongly associated with excess weight, particularly fat around the abdomen and within the liver.
What surprised surgeons initially was the speed of the effect. Blood sugar improves within days of bypass surgery, long before significant weight has been lost, and many patients leave hospital on considerably less diabetes medication than they arrived on. This is not a weight effect — it results from changes in gut hormones and bile flow that alter insulin secretion and sensitivity directly.
That observation is why these operations are now called metabolic surgery, and why they are considered for patients whose diabetes is poorly controlled even at BMI levels below traditional surgical thresholds.
The outcome depends heavily on how much pancreatic function remains. Someone diagnosed recently, not yet on insulin, with reasonable C-peptide levels, has a good chance of remission. Someone insulin-dependent for many years, whose pancreas has largely failed, will improve but is unlikely to come off treatment altogether. Both are worthwhile outcomes, but they should not be presented as the same thing.
Remission after metabolic surgery depends on how much insulin-producing capacity your pancreas retains. Duration of diabetes, whether you are on insulin, and your C-peptide level together give a reasonable estimate, and validated scores exist that combine them. A patient diagnosed two years ago and controlled on tablets has a substantially better outlook than one who has used insulin for fifteen years. That does not mean surgery is pointless in the second case — improved control and fewer medications are genuine benefits — but it means the two patients should be given different expectations. Ask specifically what remission rate applies to someone with your duration and treatment, not the clinic's headline figure.
Assessment focuses on how much pancreatic function remains.
How many years since diagnosis, which medications you have taken and when each was added, and whether you use insulin and at what dose. Those details, with your HbA1c and C-peptide, allow a realistic estimate of your chance of remission — far more reliably than a BMI figure. Add your kidney function, urine albumin and any eye assessment, since these change how surgery is planned and followed.
Surgery is one option among several, and the case is strongest where diabetes is poorly controlled despite good medical treatment.
Modern diabetes treatment includes drugs that assist both blood sugar and weight, and that protect the heart and kidneys. Many patients are not on an optimal combination, and correcting that alone improves control substantially. This should be established before surgery is considered, not skipped over.
Generally the most effective operation for type 2 diabetes, with the longest evidence base. The metabolic effect begins within days through changes in gut hormones. Many patients reduce or stop diabetes medication, and remission occurs in a substantial proportion of those with shorter-duration disease.
Also effective for diabetes, though generally somewhat less so than bypass. It is technically simpler, does not reroute the intestine, and may suit patients with previous abdominal surgery or where absorption of essential medication is a concern. It can worsen reflux.
Medication is reduced carefully and sometimes stopped entirely, but HbA1c, kidney function and eye checks continue indefinitely. Diabetes can return years later, and retinopathy occasionally worsens transiently when control improves rapidly, so eye assessment before and after matters.
The strongest predictors of remission. Shorter duration and no insulin means a considerably better chance.
C-peptide gives an indication. Very low levels suggest improvement rather than remission is the realistic goal.
Late-onset type 1 diabetes is occasionally mislabelled, and it does not respond to metabolic surgery in the same way. GAD antibodies distinguish them.
If you have used insulin for many years, we will tell you that improved control rather than remission is the realistic expectation. That is still worth having, but you should know which one you are buying.
Diabetic emergencies and infected foot ulcers are treated where you are, urgently. Coronary disease in diabetes is frequently silent and needs assessment before any operation.
Photographs taken on your phone are fine. Reports in Arabic, Russian or Bengali are fine — we translate them ourselves.
It frequently produces remission — normal blood sugar without medication — particularly where diabetes is of shorter duration and insulin is not required. Remission is not the same as cure, because diabetes can return over years and monitoring must continue. In longer-standing insulin-treated diabetes, improved control with fewer medications is the more realistic goal.
Because the effect is not primarily about weight. Bypass surgery changes gut hormone signalling and bile flow in ways that improve insulin secretion and sensitivity directly, and blood sugar improves within days — long before significant weight is lost. This is why these operations are now described as metabolic rather than simply weight-loss surgery.
Gastric bypass is generally the more effective operation for type 2 diabetes and has the longest evidence base. Sleeve gastrectomy also works and is technically simpler, and it may suit patients with previous abdominal surgery. Existing reflux, medication absorption and prior operations all influence which is appropriate for you.
Possibly. Because the effect on diabetes is not purely weight-related, surgery is considered at lower BMI thresholds where diabetes is poorly controlled despite good medical treatment — and those thresholds are lower again for South Asian patients. Your diabetes control and duration matter as much as the BMI figure.
Often much less of it, and sometimes none. Medication is reduced carefully after surgery, and insulin doses in particular need adjusting quickly to avoid low blood sugar. This is why the early period should be supervised by someone who understands both the surgery and the diabetes, rather than by dose adjustments made at home.
It can, years later, particularly where some weight is regained or where pancreatic function was already limited. This is why remission is described rather than cure, and why HbA1c monitoring continues indefinitely. Recurrence is usually more easily controlled than the original diabetes, and it is not a failure of the operation.
Send your HbA1c, how many years since diagnosis, and whether you use insulin. Those three predict your chance of remission better than any other information.
Your reports go directly to our medical team. We do not share your records with hospitals until you tell us to.
WhatsApp +91 83035 86344 · Phone +91 83035 86344 · Email tibhind@gmail.com
Coordinators available 9:00–20:00 IST. We speak Arabic, English, Russian and Bengali.